Evidence map›Paper›PMID 22111588›Full record

ArticleBMC developmental biology2011

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.

Beata Sapetto-Rebow, Sarah C McLoughlin, Lynne C O'Shea, Olivia O'Leary, Jason R Willer, Yolanda Alvarez, Ross Collery, Jacintha O'Sullivan, Freek Van Eeden, Carmel Hensey and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BMC developmental biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. DNA topological regulation in RNA polymerase II transcription.Cellular & molecular biology letters · 2026
    Review
  3. The Roles of Topoisomerases in Transcriptional Regulation.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  8. Review
  9. Article
  10. TOP2B: The First Thirty Years.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Beata Sapetto-RebowUCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
Sarah C McLoughlin
Lynne C O'Shea
Olivia O'Leary
Jason R Willer
Yolanda Alvarez
Ross Collery
Jacintha O'Sullivan
Freek Van Eeden
Carmel Hensey
Breandán N Kennedy
University College Dublin · IETrinity College Dublin · IEUniversity of Louisville · USUniversity of Pennsylvania · USUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic alterations in human topoisomerase II alpha (TOP2A) are linked to cancer susceptibility. TOP2A decatenates chromosomes and thus is necessary for multiple aspects of cell division including DNA replication, chromosome condensation and segregation. Topoisomerase II alpha is also required for embryonic development in mammals, as mouse Top2a knockouts result in embryonic lethality as early as the 4-8 cell stage. The purpose of this study was to determine whether the extended developmental capability of zebrafish top2a mutants arises from maternal expression of top2a or compensation from its top2b paralogue.

resultsHere, we describe bloody minded (blm), a novel mutant of zebrafish top2a. In contrast to mouse Top2a nulls, zebrafish top2a mutants survive to larval stages (4-5 day post fertilization). Developmental analyses demonstrate abundant expression of maternal top2a but not top2b. Inhibition or poisoning of maternal topoisomerase II delays embryonic development by extending the cell cycle M-phase. Zygotic top2a and top2b are co-expressed in the zebrafish CNS, but endogenous or ectopic top2b RNA appear unable to prevent the blm phenotype.

conclusionsWe conclude that maternal top2a enables zebrafish development before the mid-zygotic transition (MZT) and that zebrafish top2a and top2b are not functionally redundant during development after activation of the zygotic genome.

Indexed as

Embryonic DevelopmentAnimalsAntigens, NeoplasmBase SequenceCell CycleCell ExtractsDiketopiperazinesDNA-Binding ProteinsDNA Topoisomerases, Type IIFemaleGene ExpressionGene Knockout TechniquesGenes, RecessiveIsoenzymesMalePhenotype4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedioneAntigens, NeoplasmCell ExtractsDiketopiperazinesDNA-Binding ProteinsDNA Topoisomerases, Type IIIsoenzymesPiperazinesPoly-ADP-Ribose Binding ProteinsTOP2A protein, humanTop2a protein, mouseTOP2B protein, humanTop2b protein, mouseZebrafish Proteins

Identifiers

PMID22111588
PMCPMC3287258
OpenAlexW2165989868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.